Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

被引:100
|
作者
Ronneberg, Jo Anders [2 ,3 ]
Fleischer, Thomas [2 ,3 ]
Solvang, Hiroko Kato [2 ]
Nordgard, Silje H. [2 ]
Edvardsen, Hege [2 ]
Potapenko, Ivan [2 ]
Nebdal, Daniel [2 ]
Daviaud, Christian [4 ]
Gut, Ivo [4 ]
Bukholm, Ida [5 ]
Naume, Bjorn [7 ]
Borresen-Dale, Anne-Lise [2 ,3 ]
Tost, Joerg [4 ]
Kristensen, Vessela [1 ,2 ,3 ,6 ]
机构
[1] Dept Clin Mol Biol Epi Gen, Lorenskog, Norway
[2] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway
[3] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway
[4] CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet, F-91000 Evry, France
[5] Akershus Univ Hosp, Dept Surg, Nordbyhagen, Norway
[6] Univ Oslo, Fac Med, Inst Clin Epidemiol & Mol Biol EpiGen, N-0316 Oslo, Norway
[7] Oslo Univ Hosp Radiumhosp, Canc Clin, N-0310 Oslo, Norway
关键词
Breast cancer; DNA methylation; Homeobox genes; TP53; Epigenetics; Molecular classification; Gene expression; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; BONE-MARROW; DNA HYPERMETHYLATION; MOLECULAR SUBTYPES; PROGNOSTIC-FACTORS; EPITHELIAL-CELLS; OSTEOPONTIN; EPIGENETICS; PROGRESSION;
D O I
10.1016/j.molonc.2010.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a heterogeneous disease that can be divided in subtypes based on histology, gene expression profiles as well as differences in genomic aberrations. Distinct global DNA methylation profiles have been reported in normal breast epithelial cells as well as in breast tumors. However, the influence of the tumor methylome on the previously described subgroups of breast cancer is not fully understood. Here we report the DNA methylation profiles of 80 breast tumors using a panel of 807 cancer related genes interrogating 1505 CpG sites. We identified three major clusters based on the methylation profiles; one consisting of mainly tumors of myoepithelial origin and two other clusters with tumors of predominantly luminal epithelial origin. The clusters were different with respect to estrogen receptor status, TP53 status, ErbB2 status and grade. The most significantly differentially methylated genes including HDAC1, TFF1, OGG1, BMP3, FZD9 and HOXA11 were confirmed by pyrosequencing. Gene Ontology analysis revealed enrichment for genes involved in developmental processes including homeobox domain genes (HOXA9, HOXA11, PAX6, MYBL2, ISL1 and IPF1) and (ETS1, HDAC1, CREBBP, GAS7, SPI1 and TBX1). Extensive correlation to mRNA expression was observed. Pathway analyses identified a significant association with canonical (curated) pathways such as hepatic fibrosis including genes like EGF, NGFR and TNF, dendritic cell maturation and the NF-KB signaling pathway. Our results show that breast tumor expression subtypes harbor major epigenetic differences and tumors with similar gene expression profiles might belong to epigenetically different subtypes. Some of the transcription factors identified, with key roles in differentiation and development might play a role in inducing and maintaining the different phenotypes. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 50 条
  • [41] p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance
    Mueller, Sophie
    Grote, Isabel
    Bartels, Stephan
    Kandt, Leonie
    Christgen, Henriette
    Lehmann, Ulrich
    Gluz, Oleg
    Graeser, Monika
    Kates, Ron
    Harbeck, Nadia
    Kreipe, Hans
    Christgen, Matthias
    MODERN PATHOLOGY, 2023, 36 (04)
  • [42] Differences in somatic TP53 mutation type in breast tumors by race and receptor status
    Nijole C. Pollock
    Johnny R. Ramroop
    Heather Hampel
    Melissa A. Troester
    Kathleen Conway
    Jennifer J. Hu
    Jo L. Freudenheim
    Olufunmilayo I. Olopade
    Dezheng Huo
    Elad Ziv
    Susan L. Neuhausen
    Patrick Stevens
    Joseph Paul McElroy
    Amanda Ewart Toland
    Breast Cancer Research and Treatment, 2022, 192 : 639 - 648
  • [43] Differences in somatic TP53 mutation type in breast tumors by race and receptor status
    Pollock, Nijole C.
    Ramroop, Johnny R.
    Hampel, Heather
    Troester, Melissa A.
    Conway, Kathleen
    Hu, Jennifer J.
    Freudenheim, Jo L.
    Olopade, Olufunmilayo, I
    Huo, Dezheng
    Ziv, Elad
    Neuhausen, Susan L.
    Stevens, Patrick
    McElroy, Joseph Paul
    Toland, Amanda Ewart
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (03) : 639 - 648
  • [44] Significance of TP53 and immune-related genes to prostate cancer
    Huang, Hang
    Tang, Yufan
    Li, Ping
    Ye, Xueting
    Chen, Wei
    Xie, Hui
    Zheng, Yuancai
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (04) : 1754 - +
  • [45] Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer
    M Nemtsova
    V Zemlyakova
    E Kusnetsova
    V Strelnikov
    L Lyubchenko
    D Zaletayev
    Breast Cancer Research, 7
  • [46] Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer
    Nemtsova, M
    Zemlyakova, V
    Kusnetsova, E
    Strelnikov, V
    Lyubchenko, L
    Zaletayev, D
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S41 - S41
  • [47] DEVELOPING PROGNOSTIC BIOMARKER OF BREAST CANCER USING EXPRESSION PROFILE ABOUT TP53 STATUS
    Takahashi, S.
    Inoue, M.
    Fukui, T.
    Gondo, N.
    Yokoyama, S.
    Ishida, T.
    Ohuchi, N.
    Nomizu, T.
    Kakugawa, Y.
    Ishioka, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 90 - 91
  • [48] Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients
    Dobes, Petr
    Podhorec, Jan
    Coufal, Oldrich
    Jureckova, Andrea
    Petrakova, Katarina
    Vojtesek, Borivoj
    Hrstka, Roman
    ONCOLOGY REPORTS, 2014, 32 (04) : 1695 - 1702
  • [49] Coordination of TP53 Abnormalities in Breast Cancer: Data from Analysis of TP53 Polymorphisms, Loss of Heterozygosity, Methylation, and Mutations
    Denisov, Evgeny V.
    Sukhanovskaya, Tatiana V.
    Dultseva, Tatiana S.
    Malinovskaya, Elena A.
    Litviakov, Nicolay V.
    Slonimskaya, Elena M.
    Choinzonov, Evgeny L.
    Cherdyntseva, Nadezhda V.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (12) : 901 - 907
  • [50] Characterizing genomic differences of human cancer stratified by the TP53 mutation status
    Mengyao Wang
    Chao Yang
    Xiuqing Zhang
    Xiangchun Li
    Molecular Genetics and Genomics, 2018, 293 : 737 - 746